Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER-2 Positive Breast Cancer|Estrogen Receptor Positive Breast Cancer
Interventions: DRUG: palbociclib|DRUG: trastuzumab|DRUG: pertuzumab|DRUG: letrozole|DRUG: Anastrozole|DRUG: Exemestane|DRUG: Fulvestrant
Sponsor: Alliance Foundation Trials, LLC.
Collaborators: Pfizer|German Breast Group|Fondazione Michelangelo|PrECOG, LLC.|Breast Cancer Trials, Australia and New Zealand|Syneos Health|SOLTI Breast Cancer Research Group|UNICANCER